+958.0%
MRNA vs RF
+150.4%
+807.6%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | RF | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | -0.7% | -4.1% | -4.8% |
| 7D | -20.9% | -2.4% | -18.5% | -20.7% |
| 30D | -13.3% | +2.8% | -16.0% | -13.4% |
| 3M | +212.6% | -10.9% | +223.5% | +215.2% |
| 6M | +309.0% | +5.7% | +303.4% | +302.1% |
| YTD | +567.3% | +6.2% | +561.1% | +554.7% |
| 1Y | +689.7% | +20.3% | +669.4% | +662.3% |
| 3Y | +157.4% | +94.2% | +63.2% | +138.8% |
| 5Y | -21.7% | +43.8% | -65.6% | -27.3% |
| All | +958.0% | +150.4% | +807.6% | +1,048.0% |
Cumulative growth
Daily Returns
Daily percentage return beside RF.
Daily Out/Under-Performance
Portfolio return minus RF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded RF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling